Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-25
SponsorBrown University

About this trial

The goal of this treatment development project is to develop and pilot an adaptive mobile health (mHealth) intervention that targets the co-use of alcohol and opioids in young adults.

Eligibility criteria

Qualifiers

Ages 18 to 25 years, inclusive

Self-report interest in reducing their alcohol-opioid co-use - outside a research study, people who do not wish to change their co-use are unlikely to download and use an mHealth app designed to reduce co-use. It is important to recruit participants who most closely resemble the intended users of the eventual mHealth intervention. This is defined as reporting any alcohol-opioid co-use goal (i.e., not selecting "No goal" in response to the alcohol-opioid co-use goal question at the screening visit).

Self-report engaging in simultaneous alcohol-opioid co-use (i.e., use of both substances within two hours) ≥ 1 day/week on average in the past 28 days (i.e., at least 4 co-use events in the past 28 days). This requirement will ensure that we observe sufficient use episodes where the pharmacological effects of alcohol and opioids overlap to evaluate project aims.

Able to understand written and oral instructions in English, communicate understanding of the consent form, and provide written informed consent.

Disqualifiers

Pregnant or nursing

Current suicidality

History of psychosis

Trial design

Treatments tested in this trial

  • mHealth Intervention

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

Brown University

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator